Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Feb 1;175(2):481-7.
doi: 10.1084/jem.175.2.481.

Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes

Affiliations

Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes

L C Eisenlohr et al. J Exp Med. .

Abstract

Cytotoxic T lymphocytes (CTL) recognize class I major histocompatibility complex molecules complexed to peptides of eight to nine residues generated from cytosolic proteins. We find that CTL recognize, in vitro and in vivo, cells synthesizing a 10-residue peptide consisting of an initiating methionine followed by nine residues corresponding to a naturally processed determinant from influenza virus nucleoprotein (NP) (residues 147-155). Addition of two COOH-terminal residues corresponding to NP residues 157 and 158 severely reduced presentation of the endogenously produced peptide to CTL in vitro and in vivo. Extension of NH2 and COOH terminal flanking residues to include residues corresponding to NP residues 137-146 and 159-168 failed to increase the antigenicity of this peptide. Its presentation was greatly enhanced, however, by further extending the NH2 and COOH termini to include all of the additional residues of NP. These findings indicate first, that a naturally processed viral ligand (with an NH2-terminal Met) of a class I molecule contains sufficient information to access intracellular class I molecules, and second, that flanking residues can influence the processing and presentation of antigens to CTL.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1989 Sep 1;170(3):1033-8 - PubMed
    1. Nature. 1989 May 18;339(6221):223-6 - PubMed
    1. J Exp Med. 1989 Mar 1;169(3):603-12 - PubMed
    1. Cell. 1985 Sep;42(2):457-67 - PubMed
    1. Nature. 1989 Nov 9;342(6246):180-2 - PubMed

MeSH terms